» Articles » PMID: 37303738

Changes of Protein Expression During Tumorosphere Formation of Small Cell Lung Cancer Circulating Tumor Cells

Overview
Journal Oncol Res
Specialty Oncology
Date 2023 Jun 12
PMID 37303738
Authors
Affiliations
Soon will be listed here.
Abstract

Small cell lung cancer (SCLC) is frequently disseminated and has a dismal prognosis with survival times of approximately two years. This cancer responds well to initial chemotherapy but recurs within a short time as a globally chemoresistant tumor. Circulating tumor cells (CTCs) are held responsible for metastasis, the extremely high numbers of these cells in advanced SCLC allowed us to establish several permanent CTC cell lines. These CTCs are distinguished by the spontaneous formation of large spheroids, termed tumorospheres, in regular tissue culture. These contain quiescent and hypoxic cells in their interior and are associated with high chemoresistance compared to single cell cultures. Nine CTC lines were compared for their expression of 84 proteins associated with cancer either as single cells or in the form of tumorospheres in Western blot arrays. With the exception of the UHGc5 line, all other CTC lines express EpCAM and lack a complete EpCAM-negative, vimentin-positive epithelial-mesenchymal transition (EMT) phenotype. Upon formation of tumorospheres the expression of EpCAM, that mediates cell-cell adhesion is markedly upregulated. Proteins such as E-Cadherin, p27 KIP1, Progranulin, BXclx, Galectin-3, and Survivin showed variable changes for the distinct CTC cell lines. In conclusion, EpCAM presents the most critical marker for individual SCLC CTCs and the assembly of highly chemoresistant tumorospheres.

Citing Articles

Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes.

Heeke S, Gay C, Estecio M, Tran H, Morris B, Zhang B Cancer Cell. 2024; 42(2):225-237.e5.

PMID: 38278149 PMC: 10982990. DOI: 10.1016/j.ccell.2024.01.001.


Significance of circulating tumor cells in lung cancer: a narrative review.

Hamilton G, Rath B, Stickler S Transl Lung Cancer Res. 2023; 12(4):877-894.

PMID: 37197632 PMC: 10183408. DOI: 10.21037/tlcr-22-712.

References
1.
Semenova E, Nagel R, Berns A . Origins, genetic landscape, and emerging therapies of small cell lung cancer. Genes Dev. 2015; 29(14):1447-62. PMC: 4526731. DOI: 10.1101/gad.263145.115. View

2.
Laurent J, Frongia C, Cazales M, Mondesert O, Ducommun B, Lobjois V . Multicellular tumor spheroid models to explore cell cycle checkpoints in 3D. BMC Cancer. 2013; 13:73. PMC: 3598667. DOI: 10.1186/1471-2407-13-73. View

3.
Wu C, Mannan P, Lu M, Udey M . Epithelial cell adhesion molecule (EpCAM) regulates claudin dynamics and tight junctions. J Biol Chem. 2013; 288(17):12253-68. PMC: 3636909. DOI: 10.1074/jbc.M113.457499. View

4.
Yu N, Zhou J, Cui F, Tang X . Circulating tumor cells in lung cancer: detection methods and clinical applications. Lung. 2015; 193(2):157-71. DOI: 10.1007/s00408-015-9697-7. View

5.
Zschenker O, Streichert T, Hehlgans S, Cordes N . Genome-wide gene expression analysis in cancer cells reveals 3D growth to affect ECM and processes associated with cell adhesion but not DNA repair. PLoS One. 2012; 7(4):e34279. PMC: 3324525. DOI: 10.1371/journal.pone.0034279. View